Clinical Trial Update: Efficacy & Safety Study of YH22162 vs Telmisartan/Amlodipine in Patients With Hypertension Inappropriately Controlled on Telmisartan/Amlodipine Treatment [Phase 3]

View source ↗

Summary

Phase 3 efficacy and safety study comparing YH22162 to Telmisartan/Amlodipine in hypertension patients inadequately controlled on Telmisartan/Amlodipine; the tr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Telmisartan/Amlodipine (telmisartan and amlodipine)
• YH22162

Snippet

Sponsor: Yuhan Corporation | Conditions: Hypertension | Phase 3 | Status: COMPLETED